Clarivate (CLVT) Expected to Announce Quarterly Earnings on Tuesday

Clarivate (NYSE:CLVT) is projected to release its Q4 2025 results before the market opens on Tuesday, February 24th. Analysts expect Clarivate to post earnings of $0.16 per share and revenue of $604.7930 million for the quarter. Individuals may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Tuesday, February 24, 2026 at 9:00 AM ET.

Clarivate Stock Performance

NYSE:CLVT opened at $1.76 on Monday. The company’s 50-day moving average price is $2.86 and its 200-day moving average price is $3.49. The company has a current ratio of 0.87, a quick ratio of 0.87 and a debt-to-equity ratio of 0.90. The company has a market cap of $1.17 billion, a P/E ratio of -3.09 and a beta of 1.51. Clarivate has a twelve month low of $1.72 and a twelve month high of $4.98.

Insiders Place Their Bets

In other Clarivate news, insider Bar Veinstein sold 309,902 shares of the firm’s stock in a transaction on Monday, December 1st. The stock was sold at an average price of $3.74, for a total transaction of $1,159,033.48. Following the completion of the sale, the insider owned 848,811 shares of the company’s stock, valued at $3,174,553.14. This trade represents a 26.75% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 23.18% of the company’s stock.

Institutional Trading of Clarivate

Hedge funds and other institutional investors have recently modified their holdings of the business. Cetera Investment Advisers lifted its position in Clarivate by 11.2% in the second quarter. Cetera Investment Advisers now owns 26,034 shares of the company’s stock valued at $112,000 after buying an additional 2,617 shares during the last quarter. California State Teachers Retirement System raised its stake in shares of Clarivate by 0.9% in the 2nd quarter. California State Teachers Retirement System now owns 303,147 shares of the company’s stock valued at $1,304,000 after acquiring an additional 2,788 shares during the period. Envestnet Asset Management Inc. raised its stake in shares of Clarivate by 3.9% in the 3rd quarter. Envestnet Asset Management Inc. now owns 77,275 shares of the company’s stock valued at $296,000 after acquiring an additional 2,884 shares during the period. Hsbc Holdings PLC lifted its holdings in shares of Clarivate by 4.3% in the 2nd quarter. Hsbc Holdings PLC now owns 116,648 shares of the company’s stock worth $500,000 after acquiring an additional 4,792 shares during the last quarter. Finally, Advisory Services Network LLC boosted its position in shares of Clarivate by 6.7% during the 3rd quarter. Advisory Services Network LLC now owns 85,200 shares of the company’s stock worth $326,000 after purchasing an additional 5,371 shares during the period. 85.72% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. Wall Street Zen raised shares of Clarivate from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. The Goldman Sachs Group cut Clarivate from a “buy” rating to a “neutral” rating and cut their price target for the company from $4.20 to $3.60 in a report on Thursday, January 8th. Weiss Ratings reissued a “sell (e+)” rating on shares of Clarivate in a research note on Monday, December 29th. Finally, Morgan Stanley restated an “underweight” rating and issued a $3.00 target price (down from $5.00) on shares of Clarivate in a report on Wednesday, December 17th. Three equities research analysts have rated the stock with a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Clarivate currently has an average rating of “Reduce” and an average price target of $3.70.

About Clarivate

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.